Product Search for myosin heavy chain 2: Novus Biologicals

MAB4470

Myosin Heavy Chain Antibody (MF20) [Unconjugated]

(1 Review)

(186 Publications)

100 μg

MAB4470

Myosin Heavy Chain was detected in immersion fixed C2C12 mouse myoblast cell line using Mouse Anti-Human Myosin Heavy Chain Monoclonal Antibody (Catalog # MAB4470) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Mouse IgG Secondary Antibody (red; Catalog # NL007) and counter-stained with DAPI (blue). View our protocol for Fluorescent ICC Staining of Cells on Coverslips.

Myosin Heavy Chain was detected in immersion fixed paraffin-embedded sections of human skeletal muscle using Mouse Anti-Myosin Heavy Chain Monoclonal Antibody (Catalog # MAB4470) at 5 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Mouse IgG VisUCyte™ HRP Polymer Antibody (Catalog # VC001). Before incubation with the primary antibody, tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic (Catalog # CTS013). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to sarcoplasm. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents.

Myosin Heavy Chain was detected in perfusion fixed frozen sections of mouse skeletal muscle using Mouse Anti-Myosin Heavy Chain Monoclonal Antibody (Catalog # MAB4470) at 5 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Mouse IgG VisUCyte™ HRP Polymer Antibody (Catalog # VC001). Before incubation with the primary antibody, tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic (Catalog # CTS013). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to sarcoplasm. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents.

Knockdown of BAMBI inhibited myogenic differentiation. All the cell samples were harvested after transfection and myogenic induction for 48 and 96 h. (a) The western blot images of BAMBI and GAPDH; (b) the efficiency of siRNA interference on the mRNA and protein expression of BAMBI; (c) the mRNA expression of MyoD at 48 h and that of MyoG and MyHC at 96 h; (d) the western blot images of MyoD at 48 h, MyHC at 96 h, and their corresponding GAPDH; (e) the protein expression of MyoD at 48 h and MyHC at 96 h; (f) immunofluorescence of MyHC in C2C12 myotubes at 96 h post differentiation, images captured at 100× magnification; (g) the populations of myotubes; (h) the differentiation index; and (i) the myotube fusion index. The results were represented as mean ± SD; n = 3; * p 4 indicates myotubes with 4 more nucleus; (G,H) The mRNA expression of MyoD, MyoG, MyHC on 3 d and 5 d post differentiation; (I,J) The mRNA expression of Myomarker and Myomixer 3 d and 5 d post differentiation; (K) The statistical results of MyoD, MyoG, MyHC proteins in Figure 2L; (L) Western blot analyzed for MyoD, MyoG, MyHC proteins 5 d post differentiation; (M) Protein levels of key molecules in PI3K-AKT pathway in C2C12 cells transfected with miR-106a-5p agomir or NC on 5 d post differentiation; (N) The statistical analysis of phosphorylated PI3K (p85 alpha ), AKT (sre473) and mTOR (ser2448). Data were presented as mean ± SEM. n = 3 per group. * p MAB004, open histogram) followed by Allophycocyanin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # F0101B). To facilitate intracellular staining, cells were fixed with Flow Cytometry Fixation Buffer (Catalog # FC004) and permeabilized with Saponin. View our protocol for Staining Intracellular Molecules.

Sarcomere formation in contracting human myotubes on mouse fibroblast feeders. (A) After 7–8 days of differentiation, the differentiated human myotubes (derived from HSMM) on the feeder layers of mouse 3T3L1 fibroblasts were fixed and then observed for myotubular formation by using anti-human nuclear antigen (anti-HNA) and anti-Caveolin 3 antibodies, as described in the “Methods” section. DAPI was used for nuclear staining. Scale bar = 25 μm. Three independent experiments were performed, and representative images are presented. (B) The differentiated human myotubes on the mouse fibroblast feeders were subjected to either no (panels a and b) EPS or (panels c and d) EPS treatment (1 Hz frequency, 4-ms duration, 20 V/25 mm for a total 24 h of with intermittent intervals) and then fixed for evaluating sarcomere formation status by using anti-sarcomeric-alpha -actinin (green) and anti-Caveolin 3 (red) antibodies. DAPI was used for nuclear staining (blue). Scale bar = 25 μm. Magnified images (panels b and d) of the white boxes in panels a and c, respectively, are also presented. Three independent experiments were performed and representative images are presented. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/35058512), licensed under a CC-BY license. Not internally tested by R&D Systems.

Supplementation with 2-DG reduces cachexic muscle atrophy by blocking USP and ALP pathway activation in C26 conditioned medium-treated C2C12 myotubes. (A) Western blot analysis was used to evaluate atrogin-1, MuRF-1, MHC, p-STAT3, and STAT3 expression in three groups between two cachexia cell lines models. (B) Myosin heavy-chain (MHC) expression in the cell model was evaluated by immunofluorescence staining. Scale bar: 50 µM. MHC, green; Hoechst, blue. The bar graph shows the mean gray value of different groups. (C) Western blot analysis was used to evaluate atrogin-1, MuRF-1, p-STAT3, STAT3, p62, LC3, cleaved PARP, and cleaved caspase3 expression in the cell model of the four groups. Cells were treated with 5 mM 2-DG, 20 µM cisplatin, or 25 µM chloroquine for 24 h. (D) LC3 expression in the cell model was evaluated by immunofluorescence staining. Scale bar: 50 µM. LC3, green; Hoechst, blue. The bar graph shows the mean gray value of different groups. Data are expressed as the mean ± SD, * p < 0.05, ** p < 0.01 compared with NC groups; # p < 0.05, ## p < 0.01 compared with C26 CM group or TNF alpha /IFN gamma group, n = 10. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/36230949), licensed under a CC-BY license. Not internally tested by R&D Systems.

$Supplementation with creatine inhibits UPS and ALS activation, thereby preventing skeletal muscle atrophy. (A) Representative HE staining showing the morphological changes in the muscles of the three groups. Average size of muscle fiber cross-sectional area in the NC mice, cachectic mice, or creatine-treated cachectic mice. Representative Masson’s trichrome staining of paraffin sections from muscle fibers of different groups of mice is shown. The bar graph shows the collagen volume fraction (CVF) measured by ImageJ. The glycogen content was determined by Periodic Acid-Schiff (PAS) staining. The histogram shows the optical density (OD) of PAS staining. (B) Gastrocnemius myosin heavy chain (MHC) expression was evaluated by immunofluorescence (IF) staining. The bar graph shows the mean gray value of different groups. Gastrocnemius sections were stained with an antibody against laminin and DAPI. The bar graph shows the mean gray value of different groups. (C) Western blot analysis was used to evaluate MHC, Atrogin-1 and MuRF-1 expression in the three groups (mean ± SD, n = 6). *p < 0.05, **p < 0.01. (D). Western blot analysis was used to evaluate p62 and LC3 expression in the three groups (mean ± SD, n = 6). *p < 0.05, **p < 0.01. (E) Western blot analysis was used to evaluate iNOS, p-Akt, p-AMPK, p-mTOR, p-4EBP1, p-S6 and p-STAT3 in the three groups (mean ± SD, n = 6). *p < 0.05, **p < 0.01. Data are expressed as the mean ± SD. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/36569317), licensed under a CC-BY license. Not internally tested by R&D Systems.$

Supplementation with creatine prevents myotubular atrophy by inhibiting the activation of UPS and ALS. (A) Western blot analysis was performed to evaluate the expression of MHC, Atrogin-1, MuRF-1, Myostatin, p62, LC3, p-AMPK, p-Akt, p-S6 and p-4EBP1 in the NC group, cachexia group and cachexia + Cr group (mean ± SD, n = 6). *p < 0.05, **p < 0.01, ***p < 0.001. (B) Myosin heavy chain (MHC) expression in the cell model was evaluated by IF staining. MHC, green, DAPI, blue. The bar graph shows the mean gray value of different groups. (C) LC3 expression in the cell model was evaluated by IF staining. LC3, green, DAPI, blue. The bar graph shows the mean gray value of different groups. Data are expressed as the mean ± SD, **p < 0.01. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/36569317), licensed under a CC-BY license. Not internally tested by R&D Systems.

$Supplementation with creatine inhibits UPS and ALS activation, thereby preventing skeletal muscle atrophy. (A) Representative HE staining showing the morphological changes in the muscles of the three groups. Average size of muscle fiber cross-sectional area in the NC mice, cachectic mice, or creatine-treated cachectic mice. Representative Masson’s trichrome staining of paraffin sections from muscle fibers of different groups of mice is shown. The bar graph shows the collagen volume fraction (CVF) measured by ImageJ. The glycogen content was determined by Periodic Acid-Schiff (PAS) staining. The histogram shows the optical density (OD) of PAS staining. (B) Gastrocnemius myosin heavy chain (MHC) expression was evaluated by immunofluorescence (IF) staining. The bar graph shows the mean gray value of different groups. Gastrocnemius sections were stained with an antibody against laminin and DAPI. The bar graph shows the mean gray value of different groups. (C) Western blot analysis was used to evaluate MHC, Atrogin-1 and MuRF-1 expression in the three groups (mean ± SD, n = 6). *p < 0.05, **p < 0.01. (D). Western blot analysis was used to evaluate p62 and LC3 expression in the three groups (mean ± SD, n = 6). *p < 0.05, **p < 0.01. (E) Western blot analysis was used to evaluate iNOS, p-Akt, p-AMPK, p-mTOR, p-4EBP1, p-S6 and p-STAT3 in the three groups (mean ± SD, n = 6). *p < 0.05, **p < 0.01. Data are expressed as the mean ± SD. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/36569317), licensed under a CC-BY license. Not internally tested by R&D Systems.$

Has2os expression was increased in differentiated muscle cells. (A). The morphological changes in C2C12 cells before and after differentiation. D0 represents cells in growth medium, and D1, D3, and D5 represent cells switched into differentiation medium for 1, 3, or 5 days. Scale bar = 200 μm. (B). The mRNA expression levels of the myogenic marker MyHC, Mef2C, MyoD, and MyoG were measured before and after the differentiation of C2C12 cells. (C). The protein expression levels of myogenic markers MyHC and MEF2C were detected by Western blot. GAPDH was the internal control. (D). Relative expression in (C) were calculated. (E). The expression levels of Has2os in D0, D1, D3, and D5. GAPDH was the internal control. Values were presented as means ± SEM. The statistical significance was calculated by t-test. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/36359891), licensed under a CC-BY license. Not internally tested by R&D Systems.

Hoil-1l knockout C2C12 shows impaired myotube differentiation. (A) Schematic presentation of reported mutations and Hoil-1l knockout locus of C2C12 myoblast in HOIL-1L protein domains and amino acid sequences near the KO sites. (B) Immunoblot analysis of lysates of WT and Hoil-1l knockout myoblasts on day 5. Although HOIP and SHARPIN levels were decreased, HOIL-1L expression level was remarkably decreased in KO C2C12 derived myotubes. (C) Fusion index and MHC density were calculated on day 5. All data are presented as mean ± SEM. P values from Welch’s t-test. WT vs Exon 5 KO and Exon 7 KO. *P < 0.05, **P < 0.01. (D) Western blotting shows impaired expression of MHC in Hoil-1l knockout C2C12 myotube. Image collected and cropped by CiteAb from the following open publication (//www.nature.com/articles/s41598-024-57504-1), licensed under a CC-BY license. Not internally tested by R&D Systems.

The effects of CJME on CT26 conditioned medium (CM) induced-myotube atrophy. The C2C12 myoblasts were differentiated for 2 days and induced to form myotubes. (A) Effect of CJME on differentiated myotubes viability were determined using WST-1 assay. (B) Indicated CJME concentrations were used for pretreatment 1 h prior to treatment with CT26 CM for 48 h in differentiated myotubes. mRNA levels of (B) Atrogin-1 and (C) MuRF1 were determined using real-time PCR. Relative mRNA expression levels were normalized to those of GAPDH. (D) Protein levels of MyHC, Atrogin-1 and MuRF1 were analyzed via immunoblotting in cells cultured as described in B. (E) Differentiated myotubes were cultured as described in B, fixed with 4% PAF and stained with Crystal violet. Representative images of stained myotubes were shown (left). The scale bar represents 200 μm. Myotube thickness was measured using Image J 1.53 software (right) (F) Differentiated myotubes were pretreated with 20 μg/mL of CJME for 1 h and exposed to CT26 CM for various times (0, 3, 6, 12, 24, and 48 h). Then, phosphorylation of STAT1, STAT2, STAT3, ERK, JNK, p38, IKK alpha / beta and I kappa B alpha was examined using immunoblotting (left). Quantified data for STAT3 were measured using Image J 1.53 software (right) (G) Differentiated myotubes were cultured as described in B, secreted levels of IL-6 in the culture medium were measured using ELISA. Data are representative of either two independent experiments. Data are presented in terms of the mean ± standard deviation and analyzed using a one-wayANOVA or Student's t-test. P value of <0.05 (*), <0.01 (**), <0.001 (***), or <0.0001 (****) were considered statistically significant. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/40469669), licensed under a CC-BY license. Not internally tested by R&D Systems.

Reactivity:

All-Multi

Species Glossary

Reactivity: All-Multi

Applications:

, , ,

Applications: , , ,

Host:

Mouse Monoclonal

Host: Mouse Monoclonal

Sizes:

Sample Size Available

Sizes: Sample Size Available

Conjugate:

Unconjugated

Available Conjugates:

Conjugate	Catalog #	Availability	Size	Price
Alexa Fluor 350	FAB4470U-100UG
Alexa Fluor 405	FAB4470V-100UG
Alexa Fluor 488	FAB4470G-100UG
Alexa Fluor 532	FAB4470X-100UG
Alexa Fluor 594	FAB4470T-100UG
Alexa Fluor 647	FAB4470R-100UG
Alexa Fluor 700	FAB4470N-100UG
Alexa Fluor 750	FAB4470S-100UG
Allophycocyanin	IC4470A
Biotin	FAB4470B
CoraFluor 1	FAB4470CL1
DyLight 350	FAB4470D
DyLight 405	FAB4470E
DyLight 488	FAB4470K
DyLight 550	FAB4470L
DyLight 594	FAB4470M
DyLight 650	FAB4470W
DyLight 680	FAB4470Y
DyLight 755	FAB4470Z
Fluorescein	IC4470F
HRP	FAB4470H
Janelia Fluor 525	FAB4470JF525
Janelia Fluor 549	FAB4470I
Janelia Fluor 646	FAB4470J
Janelia Fluor 669	FAB4470JF669
PE	FAB4470P
PerCP	FAB4470C
mFluor Violet 450 SE	FAB4470MFV450
mFluor Violet 500 SE	FAB4470MFV500
mFluor Violet 610 SE	FAB4470MFV610

Available Formulations

Formulation	Catalog #	Availability	Price
Carrier Free	IC4470F
Carrier Free	IC4470A
Carrier Free	MAB4470-SP

compare

(select up to 3 products from this page to compare)

NBP2-94624

Myosin heavy chain 2 Antibody - BSA Free

0.1 ml

NBP2-94624

Myosin heavy chain 2 Antibody [NBP2-94624] -Analysis of mouse skeletal muscle cells using MYH2 Rabbit pAb at dilution of 1:50 (40x lens). Blue: DAPI for nuclear staining.

Myosin heavy chain 2 Antibody [NBP2-94624] -Analysis of rat skeletal muscle cells using MYH2 Rabbit pAb (A15292) at dilution of 1:50 (40x lens). Blue: DAPI for nuclear staining.

Immunocytochemistry/ Immunofluorescence: Myosin heavy chain 2 Antibody - Azide and BSA Free [Myosin heavy chain 2] - Immunofluorescence analysis of paraffin-embedded rat skeletal muscle using Myosin heavy chain 2 Rabbit pAb at dilution of 1:100 (40x lens). Secondary antibody: Cy3-conjugated Goat anti-Rabbit IgG (H+L) at 1:500 dilution. Blue: DAPI for nuclear staining.

Western Blot: Myosin heavy chain 2 Antibody - Azide and BSA Free [Myosin heavy chain 2] - Western blot analysis of lysates from U-2 OS cells using Myosin heavy chain 2 Rabbit pAb at 1:1000 dilution incubated overnight at 4C.Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25 ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit Exposure time: 60 s.

Reactivity:

Hu, Mu, Rt

Species Glossary

Reactivity: Hu, Mu, Rt

Applications:

, ,

Applications: , ,

Host:

Rabbit Polyclonal

Host: Rabbit Polyclonal

Sizes:

Sample Size Available

Sizes: Sample Size Available

Conjugate:

Unconjugated

Available Formulations

Formulation	Catalog #	Availability	Price
BSA Free	NBP2-94624-0.02ml

compare

(select up to 3 products from this page to compare)

NB100-65675

Myosin heavy chain 2 Antibody (TH81 (BGN/04/4481)) - BSA Free

(2 Publications)

0.025 mg

Reactivity:

Hu, Rt, Rb

Species Glossary

Reactivity: Hu, Rt, Rb

Applications:

, ,

Applications: , ,

Host:

Mouse Monoclonal

Host: Mouse Monoclonal

Sizes:

Sample Size Available

Sizes: Sample Size Available

Conjugate:

Unconjugated

compare

(select up to 3 products from this page to compare)

NBP3-43001

Myosin heavy chain 2 Antibody (4G9) - BSA Free

100 μg

NBP3-43001

Reactivity:

Hu

Species Glossary

Reactivity: Hu

Applications:

, ,

Applications: , ,

Host:

Mouse Monoclonal

Host: Mouse Monoclonal

Conjugate:

Unconjugated

compare

(select up to 3 products from this page to compare)

NBP3-39539

Human Myosin heavy chain 2 - Ready-To-Use ELISA Kit (Colorimetric)

1 Kit

NBP3-39539

Reactivity:

Hu

Species Glossary

Reactivity: Hu

Applications:

Applications:

Standard Curve:

0.312 - 20 ng/mL (example only; lot dependent)

Sensitivity:

0.136 ng/mL (example only; lot dependent)

Sample Type:

Serum, plasma, tissue homogenates and other biological fluids

compare

(select up to 3 products from this page to compare)

NBP3-39538

Human Myosin heavy chain 2 ELISA Kit (Colorimetric)

1 Kit

NBP3-39538

Reactivity:

Hu

Species Glossary

Reactivity: Hu

Applications:

Applications:

Standard Curve:

0.312 - 20 ng/mL (example only; lot dependent)

Sensitivity:

0.136 ng/mL (example only; lot dependent)

Sample Type:

Serum, plasma, tissue homogenates and other biological fluids

compare

(select up to 3 products from this page to compare)

NBP3-05614

Myosin heavy chain 13 Antibody - Azide and BSA Free

100 ul

NBP3-05614

Reactivity:

Mu, Rt

Species Glossary

Reactivity: Mu, Rt

Applications:

, ,

Applications: , ,

Host:

Rabbit Polyclonal

Host: Rabbit Polyclonal

Sizes:

Sample Size Available

Sizes: Sample Size Available

Conjugate:

Unconjugated

Available Formulations

Formulation	Catalog #	Availability	Price
Azide and BSA Free	NBP3-05614-20ul

compare

(select up to 3 products from this page to compare)

NBP3-29780

Myosin Heavy Chain Antibody - BSA Free

100 μg

NBP3-29780

Reactivity:

Hu

Species Glossary

Reactivity: Hu

Applications:

,

Applications: ,

Host:

Rabbit Polyclonal

Host: Rabbit Polyclonal

Conjugate:

Unconjugated

compare

(select up to 3 products from this page to compare)

NBP3-29725

Myosin Heavy Chain Antibody - BSA Free

100 μg

NBP3-29725

Reactivity:

Hu

Species Glossary

Reactivity: Hu

Applications:

,

Applications: ,

Host:

Rabbit Polyclonal

Host: Rabbit Polyclonal

Conjugate:

Unconjugated

compare

(select up to 3 products from this page to compare)

H00004621-M06

Myosin Heavy Chain 3 Antibody (3H3) - Azide and BSA Free

0.1 mg

H00004621-M06

Reactivity:

Hu

Species Glossary

Reactivity: Hu

Applications:

,

Applications: ,

Host:

Mouse Monoclonal

Host: Mouse Monoclonal

Conjugate:

Unconjugated

compare

(select up to 3 products from this page to compare)

FAB4470AFP488

Myosin Heavy Chain Antibody (MF20) [Alexa Fluor™ Plus 488]

100 μg

Reactivity:

All-Multi

Species Glossary

Reactivity: All-Multi

Host:

Mouse Monoclonal

Host: Mouse Monoclonal

Conjugate:

Alexa Fluor Plus 488

compare

(select up to 3 products from this page to compare)

FAB4470AFP594

Myosin Heavy Chain Antibody (MF20) [Alexa Fluor™ Plus 594]

100 μg

Reactivity:

All-Multi

Species Glossary

Reactivity: All-Multi

Host:

Mouse Monoclonal

Host: Mouse Monoclonal

Conjugate:

Alexa Fluor Plus 594

compare

(select up to 3 products from this page to compare)

At	=	A. thaliana	SyHa	=	Golden Syrian Hamster
All	=	All Species	Ha	=	Hamster
An	=	Animal	Hu	=	Human
ArHa	=	Armenian Hamster	I	=	Insect
Av	=	Avian	Ll	=	Llama
Bb	=	Baboon	Ma	=	Mammal
Ba	=	Bacteria	Mk	=	Monkey
Bv	=	Bovine	Mu	=	Mouse
Ca	=	Canine	Multi	=	Multi-species
Ce	=	C. Elegans	NA	=	Non-species specific
Ch	=	Chicken	Or	=	Orangutan
ChHa	=	Chinese Hamster	Pl	=	Plant
Cm	=	Cynomolgus Monkey	Pm	=	Primate
Do	=	Donkey	Po	=	Porcine
Dr	=	Drosophilia	Rb	=	Rabbit
Ec	=	E. Coli	Rt	=	Rat
Eq	=	Equine	RM	=	Rhesus Macaque
Fe	=	Feline	Sh	=	Sheep
Ft	=	Ferret	Vb	=	Vertebrate
Fi	=	Fish	Vi	=	Virus
Fu	=	Fungi	Xp	=	Xenopus
Ge	=	Gerbil	Ye	=	Yeast
GP	=	Guinea Pig	Ze	=	Zebrafish
Gt	=	Goat

Category

Protein/Target

Applications

Reactivity

Citation

Antibody Validation

Reviews

Host

Available Conjugates

Format

Modification

Clonality

Clone

Gene Symbol

Images Type

Isotype

Preservative

Research Areas

Has Sample Size

Promotional Item

Species Glossary

Myosin Heavy Chain Antibody (MF20) [Unconjugated]

Myosin heavy chain 2 Antibody - BSA Free

Myosin heavy chain 2 Antibody (TH81 (BGN/04/4481)) - BSA Free

Myosin heavy chain 2 Antibody (4G9) - BSA Free

Human Myosin heavy chain 2 - Ready-To-Use ELISA Kit (Colorimetric)

Human Myosin heavy chain 2 ELISA Kit (Colorimetric)

Myosin heavy chain 13 Antibody - Azide and BSA Free

Myosin Heavy Chain Antibody - BSA Free

Myosin Heavy Chain Antibody - BSA Free

Myosin Heavy Chain 3 Antibody (3H3) - Azide and BSA Free

Myosin Heavy Chain Antibody (MF20) [Alexa Fluor™ Plus 488]

Myosin Heavy Chain Antibody (MF20) [Alexa Fluor™ Plus 594]